HF
RKDA icon

HRT Financial’s Arcadia Biosciences RKDA Stock Holding History

HRT Financial’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60K Buy
+88,386
New +$91.5K ﹤0.01% 3726
2023
Q1 		– Sell
-2,080
Closed -$22K – 3089
2022
Q4 		$22K Buy
+2,080
New +$29.6K ﹤0.01% 2172

Other funds holding RKDA

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BWM
Bullock Wealth Management Bloomington, Indiana $231M AUM
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

HRT Financial's RKDA Position: Q2 2026 in Review

HRT Financial opened a new position in Arcadia Biosciences (RKDA) in Q2 2026: 88,386 shares worth $60K. The stake represents ﹤0.01% of the portfolio and ranks #3726 among its holdings. This is a return to the name: HRT Financial previously reported a position in RKDA as recently as Q4 2022.

HRT Financial first reported a position in RKDA in Q4 2022 and has held it in 2 quarters since. 18 funds tracked by Wall St. Rank hold RKDA as of Q2 2026.

  • HRT Financial held 88,386 shares of Arcadia Biosciences worth $60K as of Q2 2026.
  • Arcadia Biosciences was a new HRT Financial position in Q2 2026.
  • Arcadia Biosciences made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3726 holding.
  • HRT Financial first reported a position in Arcadia Biosciences in Q4 2022 and has held it in 2 quarters since.
  • 18 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.